Lumida
/AVDL
⌘K
Avadel Pharmaceuticals PLC

Avadel Pharmaceuticals PLC

AVDL
$21.64USD+0.05%+0.01 today

MARKET CAP

2.1B

P/E (TTM)

FWD P/E

DAY RANGE

$22 – $22

52W RANGE

$6
$24
STATEMENT·Income statement
USD · GAAP
METRICFY 2018FY 2019FY 2020FY 2023FY 2024TREND
Sales, Adj.$103.3M$59.2M$22.3M$28.0M$169.1M
YoY %-40.4%-42.7%-62.3%+504.8%
P / Sales
EV / Sales
Gross Profit, Adj.$85.8M$47.1M$16.6M$27.1M$153.8M
YoY %-45.4%-45.1%-64.8%+467.3%
Margin %83.0%79.5%74.3%97.0%91.0%
EV / Gross Profit
EBITDA, Adj.$-53.1M$-14.3M$-35.0M$-136.1M$-39.7M
YoY %-180.6%+73.0%-143.9%-45.2%+70.8%
Margin %-51.4%-24.2%-156.6%-486.7%-23.5%
EV / EBITDA
EBIT$-127.7M$-25.9M$-36.6M$-137.8M$-42.4M
YoY %-309.2%+79.7%-41.1%-39.9%+69.2%
Margin %-123.6%-43.8%-164.0%-493.0%-25.1%
EV / EBIT
Net Income$-95.3M$-33.2M$7.0M$-160.3M$-48.8M
YoY %-239.6%+65.1%+121.2%-16.6%+69.5%
Net Margin-92.3%-56.1%31.5%-573.2%-28.9%
EPS (GAAP)-$2.55-$0.89$0.13-$2.00-$0.51
YoY %-256.4%+65.1%+114.6%+12.7%+74.5%